{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:15:17Z","timestamp":1788804917637,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.thromres.2019.08.011","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T19:49:38Z","timestamp":1566244178000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Testosterone treatment and association with thrombin generation and coagulation inhibition in Klinefelter syndrome: A cross-sectional study"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1130-3659","authenticated-orcid":false,"given":"Simon","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Biltoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Skakkeb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Fedder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Vakur","family":"Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus H.","family":"Gravholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Marie B.","family":"M\u00fcnster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2019.08.011_bb0005","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2005-0697","article-title":"Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses","volume":"91","author":"Bojesen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.thromres.2019.08.011_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003567","article-title":"High risk of venous Thromboembolism in Klinefelter syndrome","volume":"5","author":"Zoller","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.thromres.2019.08.011_bb0015","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-15-1025","article-title":"Klinefelter syndrome, cardiovascular system, and thromboembolic disease: review of literature and clinical perspectives","volume":"175","author":"Salzano","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.thromres.2019.08.011_bb0020","doi-asserted-by":"crossref","unstructured":"Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. In: J Natl Cancer Inst. Vol 97. United States 2005:1204\u20131210.","DOI":"10.1093\/jnci\/dji240"},{"issue":"1","key":"10.1016\/j.thromres.2019.08.011_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/jc.2012-2382","article-title":"Klinefelter syndrome\u2014a clinical update","volume":"98","author":"Groth","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.thromres.2019.08.011_bb0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2017-00212","article-title":"Klinefelter syndrome - integrating genetics, neuropsychology and endocrinology","volume":"39","author":"Gravholt","year":"2018","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.thromres.2019.08.011_bb0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc06-0145","article-title":"The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism","volume":"29","author":"Bojesen","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.thromres.2019.08.011_bb0040","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/molehr\/gaq016","article-title":"Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition","volume":"16","author":"Bojesen","year":"2010","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.thromres.2019.08.011_bb0045","doi-asserted-by":"crossref","unstructured":"Kloner RA, Carson C, 3rd, Dobs A, Kopecky S, Mohler ER, 3rd. Testosterone and cardiovascular disease. J. Am. Coll. Cardiol. 2016;67(5):545-557.","DOI":"10.1016\/j.jacc.2015.12.005"},{"key":"10.1016\/j.thromres.2019.08.011_bb0050","doi-asserted-by":"crossref","unstructured":"Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. In: Mayo Clin Proc. Vol 90. England2015:224\u2013251.","DOI":"10.1016\/j.mayocp.2014.10.011"},{"issue":"11","key":"10.1016\/j.thromres.2019.08.011_bb0055","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1210\/jc.2013-1970","article-title":"Beneficial and adverse effects of testosterone on the cardiovascular system in men","volume":"98","author":"Ruige","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.thromres.2019.08.011_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/ATVBAHA.111.232876","article-title":"Association of testosterone levels with endothelial function in men: results from a population-based study","volume":"32","author":"Empen","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.thromres.2019.08.011_bb0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-11-0447","article-title":"Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study","volume":"165","author":"Corona","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.thromres.2019.08.011_bb0070","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","volume":"355","author":"Martinez","year":"2016","journal-title":"Bmj."},{"issue":"17","key":"10.1016\/j.thromres.2019.08.011_bb0075","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"Jama."},{"issue":"2","key":"10.1016\/j.thromres.2019.08.011_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2019.08.011_bb0085","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1160\/TH13-07-0566","article-title":"Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis","volume":"111","author":"Konieczynska","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.011_bb0090","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1160\/TH13-07-0587","article-title":"Individuals with coronary artery disease at a young age and features of the metabolic syndrome have an increased prothrombotic potential","volume":"111","author":"Kok","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2019.08.011_bb0095","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.thromres.2019.08.011_bb0100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke. The atherosclerosis risk in communities (ARIC) study investigators","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.thromres.2019.08.011_bb0105","first-page":"647","article-title":"Procoagulant state in current and former anabolic androgenic steroid abusers","volume":"118","author":"Chang","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"8348","key":"10.1016\/j.thromres.2019.08.011_bb0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(83)90549-4","article-title":"Effect of stanozolol on antithrombin III and protein C","volume":"2","author":"Preston","year":"1983","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.011_bb0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0049-3848(84)90165-8","article-title":"Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol","volume":"33","author":"Kluft","year":"1984","journal-title":"Thromb. Res."},{"issue":"18","key":"10.1016\/j.thromres.2019.08.011_bb0120","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.clinbiochem.2017.09.002","article-title":"Fast form alpha-2-macroglobulin - a marker for protease activation in plasma exposed to artificial surfaces","volume":"50","author":"Biltoft","year":"2017","journal-title":"Clin. Biochem."},{"issue":"5\u20136","key":"10.1016\/j.thromres.2019.08.011_bb0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"issue":"6","key":"10.1016\/j.thromres.2019.08.011_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham heart study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.thromres.2019.08.011_bb0135","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism."},{"issue":"4","key":"10.1016\/j.thromres.2019.08.011_bb0140","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1160\/TH16-10-0748","article-title":"Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women","volume":"117","author":"Sidelmann","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2019.08.011_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.blre.2012.06.001","article-title":"Thrombin generation: what have we learned?","volume":"26","author":"Al Dieri","year":"2012","journal-title":"Blood Rev."},{"issue":"8","key":"10.1016\/j.thromres.2019.08.011_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.116.003553","article-title":"Thrombin generation and Atherothrombosis: what does the evidence indicate?","volume":"5","author":"Ten Cate","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.011_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1160\/TH08-10-0667","article-title":"Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels","volume":"101","author":"Agledahl","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2019.08.011_bb0160","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1160\/TH09-02-0090","article-title":"Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels","volume":"102","author":"Agledahl","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.011_bb0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.maturitas.2013.04.012","article-title":"A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study","volume":"75","author":"Soisson","year":"2013","journal-title":"Maturitas."},{"issue":"6","key":"10.1016\/j.thromres.2019.08.011_bb0170","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2013-3576","article-title":"Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study","volume":"99","author":"Shores","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.thromres.2019.08.011_bb0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/ATVBAHA.114.304821","article-title":"Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women","volume":"35","author":"Benn","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.011_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.trsl.2008.12.004","article-title":"Regulation of thrombin generation by TFPI in plasma without and with heparin","volume":"153","author":"Brodin","year":"2009","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.thromres.2019.08.011_bb0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1139\/O07-011","article-title":"Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells","volume":"85","author":"Jin","year":"2007","journal-title":"Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.011_bb0190","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1210\/jc.2014-2834","article-title":"Anthropometry in Klinefelter syndrome--multifactorial influences due to CAG length, testosterone treatment and possibly intrauterine hypogonadism","volume":"100","author":"Chang","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.011_bb0195","doi-asserted-by":"crossref","first-page":"E518","DOI":"10.1210\/jc.2014-2780","article-title":"Gene expression patterns in relation to the clinical phenotype in Klinefelter syndrome","volume":"100","author":"Zitzmann","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.thromres.2019.08.011_bb0200","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0030-1255448","article-title":"Thrombotic complications of erythropoiesis-stimulating agents","volume":"36","author":"Lippi","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"issue":"5\u20136","key":"10.1016\/j.thromres.2019.08.011_bb0205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000083845","article-title":"Virchow's triad revisited: abnormal flow","volume":"33","author":"Lowe","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"16","key":"10.1016\/j.thromres.2019.08.011_bb0210","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2017-03-745349","article-title":"Red blood cells in thrombosis","volume":"130","author":"Byrnes","year":"2017","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.thromres.2019.08.011_bb0215","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/andr.12080","article-title":"Increased platelet reactivity in Klinefelter men: something new to consider","volume":"3","author":"Di Minno","year":"2015","journal-title":"Andrology."},{"issue":"4","key":"10.1016\/j.thromres.2019.08.011_bb0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncpuro0775","article-title":"Klinefelter syndrome in clinical practice","volume":"4","author":"Bojesen","year":"2007","journal-title":"Nat Clin Pract Urol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481930341X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481930341X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:40:21Z","timestamp":1758735621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481930341X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":44,"alternative-id":["S004938481930341X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2019.08.011","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone treatment and association with thrombin generation and coagulation inhibition in Klinefelter syndrome: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2019.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}